EGFR and inflammatory bowel disease: In human IBD, the ERRFI1 gene encoding for a feedback inhibitor of EGFR signaling has been identified as a potential risk locus53,54; thus a subset of patients may exhibit abnormal EGFR signaling and may benefit from new therapies targeting this pathway.